Health management of glaucoma
10.3760/cma.j.cn115989-20240330-00087
- VernacularTitle:青光眼的健康管理
- Author:
Weixin ZHENG
1
;
Zidong CHEN
1
;
Minbin YU
1
Author Information
1. 中山大学中山眼科中心 眼病防治全国重点实验室 广东省眼科视觉科学重点实验室，广州 510060
- Publication Type:Journal Article
- Keywords:
Glaucoma;
Health management;
Chronic disease management
- From:
Chinese Journal of Experimental Ophthalmology
2025;43(7):637-643
- CountryChina
- Language:Chinese
-
Abstract:
Glaucoma is the world's first irreversible blinding eye disease and the second leading cause of blindness.Its onset is insidious and its course is long, and if not treated in time, it can eventually lead to blindness.With the increasing population growth and aging, the number of patients with glaucoma is increasing year by year, and the patients' requirements for quality of life are becoming higher and higher, not only to see but to see well, which is a very difficult challenge for the blindness prevention of glaucoma.This paper analyzes the concept and connotation of health management and chronic disease management, and expounds the current research status, problems and challenges, and achievements of glaucoma health management at home and abroad.Combined with the 14th Five-Year Plan (2021—2025) for National Eye Health and other relevant policies and regulations issued in China in recent years, based on industry norms such as the Chinese Glaucoma Guidelines (2020) and various diagnostic and treatment requirements, the development opportunities and solutions for building a glaucoma health management model in accordance with China's national conditions are explored to guide the work of preventing glaucoma blindness, reducing the blindness rate of glaucoma and improving the level of eye health in China.
